CO2017001596A2 - Biomarcadores de enfermedad poliquística renal y usos de los mismos - Google Patents
Biomarcadores de enfermedad poliquística renal y usos de los mismosInfo
- Publication number
- CO2017001596A2 CO2017001596A2 CONC2017/0001596A CO2017001596A CO2017001596A2 CO 2017001596 A2 CO2017001596 A2 CO 2017001596A2 CO 2017001596 A CO2017001596 A CO 2017001596A CO 2017001596 A2 CO2017001596 A2 CO 2017001596A2
- Authority
- CO
- Colombia
- Prior art keywords
- patient
- pkd
- kinase
- protein
- phosphorylated
- Prior art date
Links
- 208000030761 polycystic kidney disease Diseases 0.000 title abstract 6
- 239000000090 biomarker Substances 0.000 title 1
- 102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 abstract 3
- 108010007457 Extracellular Signal-Regulated MAP Kinases Proteins 0.000 abstract 3
- 108050006400 Cyclin Proteins 0.000 abstract 2
- 102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 abstract 2
- 108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 abstract 2
- 102100036691 Proliferating cell nuclear antigen Human genes 0.000 abstract 2
- 108091008611 Protein Kinase B Proteins 0.000 abstract 2
- 102000005765 Proto-Oncogene Proteins c-akt Human genes 0.000 abstract 2
- 102000011260 Retinoblastoma Binding Proteins Human genes 0.000 abstract 2
- 108010023377 Retinoblastoma Binding Proteins Proteins 0.000 abstract 2
- 102000003861 Ribosomal protein S6 Human genes 0.000 abstract 2
- 108090000221 Ribosomal protein S6 Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000004046 Caspase-2 Human genes 0.000 abstract 1
- 108090000552 Caspase-2 Proteins 0.000 abstract 1
- 108010058546 Cyclin D1 Proteins 0.000 abstract 1
- 108010058545 Cyclin D3 Proteins 0.000 abstract 1
- 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 abstract 1
- 102100037859 G1/S-specific cyclin-D3 Human genes 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 108091005981 phosphorylated proteins Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/492—Determining multiple analytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462033031P | 2014-08-04 | 2014-08-04 | |
| PCT/US2015/043497 WO2016022500A2 (en) | 2014-08-04 | 2015-08-03 | Biomarkers of polycystic kidney disease and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2017001596A2 true CO2017001596A2 (es) | 2017-05-19 |
Family
ID=54035292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2017/0001596A CO2017001596A2 (es) | 2014-08-04 | 2017-02-17 | Biomarcadores de enfermedad poliquística renal y usos de los mismos |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10871495B2 (enExample) |
| EP (1) | EP3177932B1 (enExample) |
| JP (2) | JP6730252B2 (enExample) |
| KR (1) | KR20170033436A (enExample) |
| CN (1) | CN106716136B (enExample) |
| AU (1) | AU2015301278A1 (enExample) |
| BR (1) | BR112017002003A2 (enExample) |
| CO (1) | CO2017001596A2 (enExample) |
| MX (1) | MX2017001648A (enExample) |
| RU (1) | RU2017106891A (enExample) |
| SG (1) | SG11201700290SA (enExample) |
| WO (1) | WO2016022500A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11116755B2 (en) | 2015-11-18 | 2021-09-14 | Genzyme Corporation | Biomarker of polycystic kidney disease and uses thereof |
| GB201719520D0 (en) * | 2017-11-24 | 2018-01-10 | Univ College Cardiff Consultants Ltd | Neuroprotectvie peptide |
| KR102859441B1 (ko) * | 2019-11-22 | 2025-09-12 | 서울대학교산학협력단 | Opn 검출용 제제를 포함하는, 다낭신의 진단용 조성물 및 이의 이용 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003500418A (ja) * | 1999-05-24 | 2003-01-07 | エイブイアイ バイオファーマ， インコーポレイテッド | 多発性嚢胞腎疾患の処置のためのｃ−ｍｙｃに対するアンチセンス |
| US9006181B2 (en) | 2004-07-21 | 2015-04-14 | The Administrators Of The Tulane Educational Fund | Treatment of renal dysfunction and multiple myeloma using PACAP compounds |
| EP1808694A1 (en) | 2006-01-17 | 2007-07-18 | Universitätsklinikum Freiburg | Method for diagnosing polycystic kidney disease |
| US20120077263A1 (en) | 2009-06-05 | 2012-03-29 | Mayo Foundation For Medical Education And Research | Methods and materials for isolating exosomes |
| CN102018702B (zh) * | 2009-09-16 | 2012-07-18 | 北京大学 | 银杏内酯b的一种用途 |
| US20140079769A1 (en) * | 2010-10-01 | 2014-03-20 | Fabiola Terzi | Methods for predicting the progression and treating a chronic kidney disease in a patient |
| US20130276513A1 (en) * | 2010-10-14 | 2013-10-24 | The Regents Of The University Of California | Methods for diagnosing and assessing kidney disease |
| ES2982997T3 (es) | 2012-07-03 | 2024-10-21 | Fond Centro San Raffaele | 2-desoxiglucosa para uso en el tratamiento de la enfermedad renal poliquística dominante autosomal o enfermedad hepática poliquística |
| JOP20130273B1 (ar) | 2012-09-11 | 2021-08-17 | Genzyme Corp | مثبطات انزيم (سينثاز) غلوكوسيل سيراميد |
-
2015
- 2015-08-03 JP JP2017506291A patent/JP6730252B2/ja active Active
- 2015-08-03 AU AU2015301278A patent/AU2015301278A1/en not_active Abandoned
- 2015-08-03 SG SG11201700290SA patent/SG11201700290SA/en unknown
- 2015-08-03 BR BR112017002003A patent/BR112017002003A2/pt not_active Application Discontinuation
- 2015-08-03 WO PCT/US2015/043497 patent/WO2016022500A2/en not_active Ceased
- 2015-08-03 RU RU2017106891A patent/RU2017106891A/ru not_active Application Discontinuation
- 2015-08-03 MX MX2017001648A patent/MX2017001648A/es unknown
- 2015-08-03 KR KR1020177005740A patent/KR20170033436A/ko not_active Withdrawn
- 2015-08-03 EP EP15757363.5A patent/EP3177932B1/en active Active
- 2015-08-03 US US15/501,496 patent/US10871495B2/en active Active
- 2015-08-03 CN CN201580053081.4A patent/CN106716136B/zh active Active
-
2017
- 2017-02-17 CO CONC2017/0001596A patent/CO2017001596A2/es unknown
-
2020
- 2020-07-01 JP JP2020113693A patent/JP7005695B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3177932A2 (en) | 2017-06-14 |
| JP2020170013A (ja) | 2020-10-15 |
| RU2017106891A3 (enExample) | 2019-03-14 |
| RU2017106891A (ru) | 2018-09-06 |
| EP3177932B1 (en) | 2021-07-14 |
| JP6730252B2 (ja) | 2020-07-29 |
| JP7005695B2 (ja) | 2022-02-04 |
| CN106716136A (zh) | 2017-05-24 |
| BR112017002003A2 (pt) | 2017-12-12 |
| CN106716136B (zh) | 2020-06-23 |
| KR20170033436A (ko) | 2017-03-24 |
| US20170227551A1 (en) | 2017-08-10 |
| MX2017001648A (es) | 2017-04-27 |
| US10871495B2 (en) | 2020-12-22 |
| WO2016022500A3 (en) | 2016-04-07 |
| SG11201700290SA (en) | 2017-02-27 |
| WO2016022500A2 (en) | 2016-02-11 |
| JP2017525955A (ja) | 2017-09-07 |
| AU2015301278A1 (en) | 2017-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR107078A1 (es) | Anticuerpo antimiostatina, polipéptidos que contienen regiones fc variantes así como métodos de uso | |
| UY37340A (es) | Antianticuerpos gprc5d, moléculas de unión al antígeno biespecíficas que se unen a gprc5d y cd3, y usos de estas | |
| IL262367A (en) | Methods, systems and kits for sequestration pen-based assays | |
| MX2019014009A (es) | Metodos mejorados para la elaboracion de terapias celulares adoptivas. | |
| WO2012094580A3 (en) | Compounds that modulate oxidative stress | |
| AR103161A1 (es) | Anticuerpos antimiostatina y regiones fc variantes así como métodos de uso | |
| MX2017007941A (es) | Anticuerpos antagonistas anti-axl. | |
| IL251188A0 (en) | Central memory t cells for adoptive t cell therapy | |
| MX2017008819A (es) | Anticuerpos anti-cd47 y usos de los mismos. | |
| MX2018002634A (es) | Impulsores de grapas de un cartucho de grapas quirurgicas con caracteristicas de soporte central. | |
| MX2018008106A (es) | Terapias con celulas inmunoefectoras de una eficacia mejorada. | |
| MX2016009555A (es) | Proteinas de union y metodos para utilizarlas. | |
| CO2018012513A2 (es) | Anticuerpos | |
| BR112017024256A2 (pt) | meio de transmissão que tem múltiplos núcleos e métodos para uso com o mesmo. | |
| PE20190229A1 (es) | Anticuerpos anti-fcrn | |
| EP3277294C0 (en) | METHOD FOR IDENTIFYING HUMAN COMPATIBILITY-SPECIFIC T CELL RECEPTORS FOR AN ANTIGEN TARGET | |
| MX2016010956A (es) | Capas implantables que comprenden una region presionada. | |
| AR095363A1 (es) | Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1 | |
| BR112016028512A2 (pt) | métodos de cultivo por perfusão e seu uso | |
| UY35718A (es) | Anticuerpos anti-csf-1r: métodos de expresión de los mismos. | |
| SI3365432T1 (sl) | Terapija z matičnimi celicami, na osnovi matičnih celic iz adipoze | |
| AR101268A1 (es) | Dispositivos para ensayos, métodos para realizar ensayos, kits para ensayos y método para fabricar dispositivos para ensayos | |
| MX2020008403A (es) | Receptores de celulas t especificos de ciclina a1 y usos de los mismos. | |
| EP3475412A4 (en) | CELL CULTURE CONTAINER | |
| CO2017001596A2 (es) | Biomarcadores de enfermedad poliquística renal y usos de los mismos |